Cellyan Biotechnology Co., Ltd (HKPD) ist ein börsennotiertes Unternehmen im Gesundheitswesen Sektor, tätig in der Medical - Pharmaceuticals Branche. Der Hauptsitz des Unternehmens ist in Yau Tong, Hong Kong. Der aktuelle CEO ist Chenyu Liang.
HKPD hat IPO-Datum 2025-01-15, 27 Vollzeitbeschäftigte, gelistet an der NASDAQ Capital Marke, eine Marktkapitalisierung von $7.63M.
Cellyan Biotechnology Co., Ltd, an investment holding company, engages in the over the counter (OTC) pharmaceutical business in Hong Kong and Mainland China. The company provides OTC pharmaceutical cross-border procurement and distribution and e-commerce supply chain services. It also offers custom clearance, drugs enlisting, warehouse, and other logistics services. The company serves e-commerce platform logistics partners, merchants, and pharmaceutical distributors. The company was formerly known as Hong Kong Pharma Digital Technology Holdings Limited and changed its name to Cellyan Biotechnology Co., Ltd in December 2025. Cellyan Biotechnology Co., Ltd was incorporated in 2023 and is based in Yau Tong, Hong Kong.
